MRI FEATURES OF COMMON PAROTID GLAND TUMORS: DIFFERENTIATING BENIGN AND MALIGNANT LESIONS

Đoàn Nhật Vy Võ , Sĩ Bảo Nguyễn, Quang Huy Huỳnh

Main Article Content

Abstract

Objectives: To characterize the magnetic resonance imaging (MRI) features of common benign and malignant parotid gland tumors (PGTs) and to evaluate the diagnostic value of MRI—particularly diffusion-weighted imaging (DWI) and the apparent diffusion coefficient (ADC)—for differentiating benign from malignant lesions. Methods: We conducted a cross-sectional descriptive study of 39 patients with PGTs who underwent MRI at Ho Chi Minh City Oncology Hospital, Viet Nam, between January 2019 and June 2025, with histopathology as the reference standard. Conventional MRI morphology and DWI were assessed. Quantitative measurements included lesion ADC (ROI placed on the solid components), ADC of normal parotid parenchyma, and the ratio rADC (lesion-to-parotid ADC). Results: Compared with benign PGTs, malignant tumors more frequently exhibited ill-defined margins, absence of a capsule, peritumoral edema (60.9%), invasion of adjacent tissues (47.8%), and cervical lymphadenopathy (30.4%) (all p<0.05). On DWI, 56.5% of malignant PGTs showed marked diffusion restriction (high DWI signal with low ADC), whereas most benign tumors did not. Mean lesion ADC measured in the solid components was significantly lower in malignant than in benign tumors (p<0.001). Receiver operating characteristic (ROC) analysis with the maximal Youden index identified an optimal ADC cutoff of 1.06 × 10⁻³ mm²/s, yielding 78.3% sensitivity and 93.7% specificity for malignancy. The rADC was also significantly lower in malignant tumors (1.04) than in benign ones (1.32; p=0.001). Conclusion: MRI reliably differentiates benign from malignant parotid gland tumors. A combined approach—systematic assessment of morphological features together with quantitative ADC measured in the solid tumor components—provides strong diagnostic discrimination.

Article Details

References

Gökçe E. Multiparametric Magnetic Resonance Imaging for the Diagnosis and Differential Diagnosis of Parotid Gland Tumors. J Magn Reson Imaging. 2020 Jul;52(1):11–32.
2. Thoeny HC. Imaging of salivary gland tumours. Cancer Imaging. 2007 Apr 30;7(1):52–62.
3. Habermann CR, Arndt C, Graessner J, Diestel L, Petersen KU, Reitmeier F, et al. Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? AJNR Am J Neuroradiol. 2009 Mar;30(3):591–6.
4. Christe A, Waldherr C, Hallett R, Zbaeren P, Thoeny H. MR Imaging of Parotid Tumors: Typical Lesion Characteristics in MR Imaging Improve Discrimination between Benign and Malignant Disease. American Journal of Neuroradiology. 2011 Aug 1;32(7):1202–7.
5. Kim SY, Borner U, Lee JH, Wagner F, Tshering Vogel DW. Magnetic resonance imaging of parotid gland tumors: a pictorial essay. BMC Med Imaging. 2022 Nov 7;22:191.
6. Vogl TJ, Dresel SH, Späth M, Grevers G, Wilimzig C, Schedel HK, et al. Parotid gland: plain and gadolinium-enhanced MR imaging. Radiology. 1990 Dec;177(3):667–74.
7. Faheem M, Refaat M. Role of magnetic resonance imaging (MRI) including diffusion weighted images (DWIs) in assessment of parotid gland masses with histopathological correlation. The Egyptian Journal of Radiology and Nuclear Medicine. 2018 May 9;49.
8. Bruvo M, Mahmood F. Apparent diffusion coefficient measurement of the parotid gland parenchyma. Quant Imaging Med Surg. 2021 Aug;11(8):3812–29.
9. Karaman CZ, Tanyeri A, Özgür R, Öztürk VS. Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results. Dentomaxillofac Radiol. 2021 May 1;50(4):20200391.
10. Espinoza S, Halimi P. Interpretation pearls for MR imaging of parotid gland tumor. Eur Ann Otorhinolaryngol Head Neck Dis. 2013 Feb;130(1):30–5.